Benzinga | Nov 20, 2020 04:07PM EST

Aridis Pharmaceuticals Q3 EPS $(0.65) Up From $(0.87) YoY

Aridis Pharmaceuticals (NASDAQ:ARDS) reported quarterly losses of $(0.65) per share. This is a 25.29 percent increase over losses of $(0.87) per share from the same period last year.